6th July 2018
Imugene Limited (Company) is pleased to announce the results of the fully underwritten 1 for 9.5 non- renounceable pro rata rights issue (Rights Issue) offer to raise approximately $8.1 million (before the exercise of any New Options).
The Company refers to its Rights Issue as announced on 7 June 2018. The following notice is given in accordance with Appendix 7A of the ASX Listing Rules.
For further information please download PDF attached:
Download this document
